LONDON, Nov. 16, 2017 /PRNewswire/ -- Fore Pharma announced the results of its Irritable Bowel Syndrome patients study in a new report 'Global Irritable Bowel Syndrome Epidemiology and Patient Flow Analysis - 2017'.
Download the full report: https://www.reportbuyer.com/product/3895256
The report provides insights into Irritable Bowel Syndrome epidemiology, Irritable Bowel Syndrome diagnosed patients, and Irritable Bowel Syndrome treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Irritable Bowel Syndrome derived from epidemiological analysis, percentage of patients diagnosed with Irritable Bowel Syndrome, and percentage of patients treated with a therapy.
The study helps executives estimate Irritable Bowel Syndrome market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions. The report provides estimates and forecasts of Irritable Bowel Syndrome prevalence, Irritable Bowel Syndrome diagnosis rate, and Irritable Bowel Syndrome treatment rate for the period 2016 - 2025. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.
Key Features of the Report: - Irritable Bowel Syndrome Patient Flow - Irritable Bowel Syndrome Prevalence - Irritable Bowel Syndrome Diagnosed Patients - Irritable Bowel Syndrome Treated PatientsDownload the full report: https://www.reportbuyer.com/product/3895256 About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: [email protected] Tel: +44 208 816 85 48 Website: www.reportbuyer.com
Advertisement
Download the full report: https://www.reportbuyer.com/product/3895256
The report provides insights into Irritable Bowel Syndrome epidemiology, Irritable Bowel Syndrome diagnosed patients, and Irritable Bowel Syndrome treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Irritable Bowel Syndrome derived from epidemiological analysis, percentage of patients diagnosed with Irritable Bowel Syndrome, and percentage of patients treated with a therapy.
Advertisement
The study helps executives estimate Irritable Bowel Syndrome market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions. The report provides estimates and forecasts of Irritable Bowel Syndrome prevalence, Irritable Bowel Syndrome diagnosis rate, and Irritable Bowel Syndrome treatment rate for the period 2016 - 2025. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.
Key Features of the Report: - Irritable Bowel Syndrome Patient Flow - Irritable Bowel Syndrome Prevalence - Irritable Bowel Syndrome Diagnosed Patients - Irritable Bowel Syndrome Treated PatientsDownload the full report: https://www.reportbuyer.com/product/3895256 About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: [email protected] Tel: +44 208 816 85 48 Website: www.reportbuyer.com
View original content:http://www.prnewswire.com/news-releases/global-irritable-bowel-syndrome-epidemiology-and-patient-flow-analysis---2017-300558345.html
SOURCE ReportBuyer
